Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the Company will ...

Sandra Amis, an international development leader with more than 25 years of experience, was appointed as chief administrative officer of CRDF Global, a nonprofit organization that delivers security ...

Cardiff Oncology CRDF announced robust efficacy data from an ongoing mid-stage study evaluating two doses of its lead investigational candidate, onvansertib (20 mg and 30 mg), in combination with ...

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At ...

In recent years, major geopolitical events like the Russian re-invasion of Ukraine have taught global leaders important lessons about potential future conflicts, the importance of cybersecurity and ...

Three scientists from India, Singapore, and Africa are recipients of the 2021 Victor Rabinowitch Memorial Award for Young Leaders in International Scientific Cooperation. Rabinowitch was a lifelong ...

Cardiff Oncology Inc. Annual stock financials by MarketWatch. View the latest CRDF financial statements, income statements and financial ratios.